A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma

  • Salvatori R
  • Daly A
  • Quinones-Hinojosa A
  • et al.
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Heterozygous germline inactivating mutations in the aryl hydrocarbon receptor-interacting protein ( AIP ) gene lead to pituitary adenomas that most frequently present in the setting of familial isolated pituitary adenoma syndrome, usually as somatotropinomas and prolactinomas. More recently, they have been found in a significant percentage of young patients presenting with pituitary macroadenoma without any apparent family history. We describe the case of a 19-year-old man who presented with a gigantic somatotropinoma. His family history was negative. His peripheral DNA showed a heterozygous AIP mutation (p.I13N), while tumor tissue only had the mutated allele, showing loss of heterozygosity (LOH) and suggesting that the mutation caused the disease.

Cite

CITATION STYLE

APA

Salvatori, R., Daly, A. F., Quinones-Hinojosa, A., Thiry, A., & Beckers, A. (2014). A clinically novel AIP mutation in a patient with a very large, apparently sporadic somatotrope adenoma. Endocrinology, Diabetes & Metabolism Case Reports, 2014. https://doi.org/10.1530/edm-14-0048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free